Z. Yang
3 Papers
Z. Yang is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
OP24 Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn’s Disease: Week 48 analyses from the phase 2 GALAXI 1 study
Silvio Danese,Remo Panaccione,D. Rubin,B.E. Sands,Walter Reinisch,Geert R. D'Haens,Julián Panés,S. González,Kathleen M. Weisel,A. Sahoo,Mary Ellen Frustaci,Z. Yang,W J Sandborn,Anita Afzali,Tadanori Hisamatsu,Jane M. Andrews,BG Feagan +16 more
TL;DR: GUS induction followed by SC maintenance achieved high rates of clinical efficacy at Wk48 and key safety event rates were similar among GUS dose groups (Table 3); no opportunistic infections, cases of tuberculosis, or deaths were reported in any group.
17
Pos-624 the efficacy and safety of roxadustat in treating anemia in hemodialysis patients with erythropoietin-hyporesponsive
TL;DR: In this paper , the authors evaluated the safety and efficacy of roxadustat in treating patients with anemia due to chronic kidney disease and showed that the drug can significantly increase hemoglobin level, improving iron absorption and utilization, reduce cholesterol and had high short-term safety in hemodialysis patients with erythropoietin-hyporesponsive anemia.
P473 Corticosteroid-free clinical remission rates with guselkumab maintenance therapy in patients with moderately to severely active Crohn’s disease: Week 48 analyses from the phase 2 GALAXI 1 study
Geert R. D'Haens,Anita Afzali,Renata Filip,Abdiel de Lira Rolim,Natalie A. Terry,Leonardo Salese,Aparna Sahoo,Mary Ellen Frustaci,Z. Yang,Jane M. Andrews,Silvio Danese,Tadanori Hisamatsu +11 more
TL;DR: GALAXI 1, a phase 2b, double-blind, placebo (PBO)-controlled study, evaluated efficacy and safety of guselkumab (GUS), a selective interleukin-23p19 subunit antagonist, in patients with moderately to severely active Crohn's disease (CD) as discussed by the authors .